Philips recently showcased its latest innovations in radiation therapy at the ASTRO 2025 Annual Meeting. The company introduced the Philips Rembra RT and Philips Areta RT CT platforms, which aim to enhance precision in cancer care. These advancements are designed to improve accuracy and efficiency in radiation therapy, addressing the increasing complexities of treatment planning. Citigroup maintains a Neutral rating for Philips (NYSE:PHG), with a raised price target, indicating cautious optimism. Philips in ...

September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term valuePhilips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology Amsterdam, the Netherlands – At the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will intr ...